Which mutual funds hold Concord Biotech Limited?

12 mutual funds hold Concord Biotech Limited as of Sep 2026. The highest weight is 2.7% held by DSP Healthcare Fund - Direct Plan - Growth. Data from official AMFI monthly portfolio disclosures.

What sector is Concord Biotech Limited in?

Concord Biotech Limited is in the Pharmaceuticals & Biotechnology sector and is categorised as by SEBI.

What is the SEBI market cap category of Concord Biotech Limited?

As per SEBI and AMFI classification (Jan-Jun 2026), Concord Biotech Limited is a Small Cap stock ranked #496 with an average market cap of ₹12.38 K Cr.

Pharmaceuticals & Biotechnology

Concord Biotech Limited

ISIN: INE338H01029 · Data as of Sep 2026

Share: WhatsApp ✕ X

Search another stock:

Active Funds Holding

vs Last Month

-1 funds

Total Value

₹783.27 Cr

Avg Weight

1.28%

New Entries

Exits

Top Holder

DSP Healthcare Fund - Direct Plan - Growth 2.7%

ℹ️ Index funds and ETFs are excluded. Only actively managed funds reflect genuine fund manager decisions.

Small Cap Rank #496

₹12.38 K Cr

Avg Mkt Cap · Jan-Jun 2026 (latest)

SEBI · AMFI Market Cap List

📋 What Changed This Month Concord Biotech Limited is currently held by 12 active mutual funds with total exposure of ₹783.27 Cr. This month 1 fund entered and 2 funds exited. DSP Healthcare Fund - Direct Plan - Growth has the highest allocation at 2.7%. ↓ Scroll down for full fund list and monthly changes.

Trend

How Has Fund Coverage Changed — Last 5 Months?

Month	Funds	AUM (Cr)	AMCs	Status
Sep 2026 REFERENCE	12	₹783	48 / 49
Aug 2026	13	₹863	49 / 49	✅ Complete
Jul 2026	16	₹611	49 / 49	✅ Complete
Jun 2026	16	₹550	49 / 49	✅ Complete
May 2026	13	₹397	49 / 49	✅ Complete

📌 Portfolio changes below are based on Sep 2026 data — the most complete month with 48 AMCs we cover uploaded.

This Month

What Changed in the Portfolio — Sep 2026?

Note: Index funds and ETFs are excluded from this analysis. Their holdings change due to index rebalancing, not active fund manager decisions, and do not reflect genuine conviction buys or exits.

▲ New Entries (1)

ITI Flexi Cap Fund- Direct Plan- Growth 1.01%

▼ Exits (2)

quant Healthcare Fund - Growth Option - Direct Plan 7.03%

Invesco India Flexi Cap Fund - Direct Plan - Growth 0.45%

↑ Increased (1)

Baroda BNP Paribas Innovation Fund Direct plan - Growth Option +0.02%

↓ Decreased (9)

DSP Healthcare Fund - Direct Plan - Growth -0.07%

SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH -0.15%

Baroda BNP Paribas Health and Wellness Fund Direct Growth -0.03%

DSP Small Cap Fund - Direct Plan - Growth -0.07%

Edelweiss Small Cap Fund - Direct Plan - Growth -0.02%

SBI Balanced Hybrid Fund -0.09%

Helios Mid Cap Fund - Direct Plan - Growth Option -0.09%

Helios Small Cap Fund - Direct Plan - Growth Option -0.11%

By Category

Which Fund Categories Hold This Stock?

Category	Funds	Avg Weight
Equity	7	1.43%
Small Cap	3	1.18%
Flexi Cap	1	1.01%
Mid Cap	1	0.79%

All Holdings

Which 12 Active Funds Hold Concord Biotech Limited?

Filter:

Fund ↕	Category ↕	Weight ↕	Value ↕	Change ↕
DSP Healthcare Fund - Direct Plan - Growth DSP Mutual Fund	Equity	2.7%	₹101.07 Cr	-0.07%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH SBI Mutual Fund	Equity	2.25%	₹131.87 Cr	-0.15%
Baroda BNP Paribas Health and Wellness Fund Direct Growth Baroda BNP Paribas Mutual Fund	Equity	2.11%	₹10.30 Cr	-0.03%
DSP Small Cap Fund - Direct Plan - Growth DSP Mutual Fund	Small Cap	1.68%	₹359.86 Cr	-0.07%
Baroda BNP Paribas Innovation Fund Direct plan - Growth Option Baroda BNP Paribas Mutual Fund	Equity	1.28%	₹10.99 Cr	+0.02%
Edelweiss Small Cap Fund - Direct Plan - Growth Edelweiss Mutual Fund	Small Cap	1.11%	₹77.58 Cr	-0.02%
ITI Flexi Cap Fund- Direct Plan- Growth ITI Mutual Fund	Flexi Cap	1.01%	₹16.07 Cr	NEW
SBI Balanced Hybrid Fund SBI Mutual Fund	Equity	0.83%	₹16.48 Cr	-0.09%
Helios Mid Cap Fund - Direct Plan - Growth Option Helios Mutual Fund	Mid Cap	0.79%	₹18.55 Cr	-0.09%
Helios Small Cap Fund - Direct Plan - Growth Option Helios Mutual Fund	Small Cap	0.76%	₹14.36 Cr	-0.11%
CANARA ROBECO MANUFACTURING FUND Canara Robeco Mutual Fund	Equity	0.64%	₹10.79 Cr	-0.01%
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option Nippon India Mutual Fund	Equity	0.17%	₹15.35 Cr	—

Explore More

← Stock Search Top Stocks by MF Conviction Fund Directory AMC AAUM Rankings Market Cap Categories

Data source: Official AMFI monthly portfolio disclosures. Updated every month. Index funds and ETFs excluded. Disclaimer: This is not investment advice. Consult a SEBI-registered advisor before investing.